Werewolf Therapeutics, Inc.
HOWL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785530
In the last 90 days, Werewolf Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $3.91M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Werewolf Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- −2 vs. Q2 2022
- Shares held
- 21.0M
- +1.88M (+9.9%) vs. Q2 2022
- Total value
- $94.5M
- +$16.5M (+21.1%) vs. Q2 2022
- New holders
- 4
- 13 more added
- Sold out
- 6
- 12 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HOWL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $3.91M |
| Q1 2026 | 48 | $11.7M |
| Q4 2025 | 51 | $9.34M |
| Q3 2025 | 62 | $41.6M |
| Q2 2025 | 65 | $24.3M |
| Q1 2025 | 70 | $26.7M |
| Q4 2024 | 73 | $41.7M |
| Q3 2024 | 69 | $68.3M |
| Q2 2024 | 71 | $79.3M |
| Q1 2024 | 61 | $209.7M |
| Q4 2023 | 41 | $106.8M |
| Q3 2023 | 35 | $51.1M |
| Q2 2023 | 36 | $73.3M |
| Q1 2023 | 38 | $62.5M |
| Q4 2022 | 39 | $42.8M |
| Q3 2022 | 44 | $94.5M |
| Q2 2022 | 46 | $78.0M |
| Q1 2022 | 49 | $84.3M |
| Q4 2021 | 51 | $228.4M |
| Q3 2021 | 42 | $326.2M |
| Q2 2021 | 45 | $344.3M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Werewolf Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 4,291,881 | $19.4M | 0.41% | 00.0% | Unchanged |
| MPM Asset Management LLC | 4,284,172 | $19.3M | 7.36% | 00.0% | Unchanged |
| PFM Health Sciences, LP | 2,815,654 | $12.7M | 0.49% | +1,084,931+62.7% | Added |
| MPM Oncology Impact Management LP | 2,388,011 | $10.8M | 2.55% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,000,597 | $4.51M | 0.01% | 00.0% | Unchanged |
| Rubric Capital Management LP | 966,879 | $4.36M | 0.22% | +761,883+371.7% | Added |
| Deerfield Management Company, L.P. (Series C) | 958,125 | $4.32M | 0.09% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 626,810 | $2.83M | 0.50% | +29,807+5.0% | Added |
| DC Funds, LP | 589,102 | $2.66M | 40.05% | 00.0% | Unchanged |
| Laurion Capital Management LP | 522,900 | $2.36M | 0.07% | −12,260−2.3% | Reduced |
| Millennium Management LLC | 511,608 | $2.31M | 0.00% | +262,691+105.5% | Added |
| Vanguard Group Inc | 435,256 | $1.96M | 0.00% | +39,187+9.9% | Added |
| FMR LLC | 337,073 | $1.52M | 0.00% | −181,699−35.0% | Reduced |
| Oasis Management Co Ltd. | 246,305 | $1.11M | 0.19% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 206,201 | $930.0K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 148,009 | $668.0K | 0.00% | −35,948−19.5% | Reduced |
| Geode Capital Management, LLC | 120,287 | $542.0K | 0.00% | +41,007+51.7% | Added |
| Ergoteles LLC | 114,595 | $517.0K | 0.02% | −14,405−11.2% | Reduced |
| Platinum Investment Management Ltd | 109,530 | $494.0K | 0.02% | −103,851−48.7% | Reduced |
| Caas Capital Management LP | 62,599 | $256.0K | 0.03% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 41,711 | $188.0K | 0.01% | +5,500+15.2% | Added |
| Dimensional Fund Advisors LP | 25,996 | $117.0K | 0.00% | +25,996 | New |
| State Street Corp | 24,568 | $111.0K | 0.00% | 00.0% | Unchanged |
| Bailard, Inc. | 20,200 | $91.0K | 0.00% | −1,000−4.7% | Reduced |
| Qube Research & Technologies Ltd | 19,908 | $90.0K | 0.00% | −2,627−11.7% | Reduced |
| Dynamic Technology Lab Private Ltd | 19,558 | $88.0K | 0.01% | +19,558 | New |
| Northern Trust Corp | 18,553 | $84.0K | 0.00% | +4,735+34.3% | Added |
| Renaissance Technologies LLC | 18,300 | $83.0K | 0.00% | +1,500+8.9% | Added |
| Morgan Stanley | 10,487 | $47.0K | 0.00% | −11,799−52.9% | Reduced |
| Tower Research Capital LLC (TRC) | 6,531 | $30.0K | 0.00% | +4,188+178.7% | Added |
| Denali Advisors LLC | 5,900 | $27.0K | 0.01% | +5,900 | New |
| Bank of America Corp | 3,478 | $15.0K | 0.00% | +784+29.1% | Added |
| UBS Group AG | 2,450 | $11.0K | 0.00% | −1,807−42.4% | Reduced |
| JPMorgan Chase & Co | 1,500 | $7.00K | 0.00% | −2,198−59.4% | Reduced |
| Oliver Lagore Vanvalin Investment Group | 580 | $3.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 427 | $2.00K | 0.00% | −309−42.0% | Reduced |
| Royal Bank of Canada | 387 | $2.00K | 0.00% | +154+66.1% | Added |
| Financial Perspectives, Inc | 250 | $1.13K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 277 | $1.00K | 0.00% | +277 | New |
| Wells Fargo & Company | 88 | $0 | 0.00% | +38+76.0% | Added |
| Group One Trading, L.P. | 15 | $0 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 80 | $0 | 0.00% | 00.0% | Unchanged |
| Glassman Wealth Services | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Ellevest, Inc. | 12 | $0 | 0.00% | −19−61.3% | Reduced |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −13,250−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −10,983−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −11,124−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −187−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −108−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −14−100.0% | Sold out |